The Contemporary Role of Salvage Radical Prostatectomy in the Management of Recurrent Prostate Cancer: An Up-to-Date Review

被引:0
|
作者
Katsimperis, Stamatios [1 ]
Pinitas, Alexandros [2 ]
Zerva, Maria [3 ]
Bellos, Themistoklis [1 ]
Manolitsis, Ioannis [1 ]
Feretzakis, Georgios [4 ]
Verykios, Vassilios S. [4 ]
Kyriazis, Ioannis [1 ]
Neofytou, Panagiotis [1 ]
Kapsalos, Sotirios [1 ]
Deligiannis, Panagiotis [1 ]
Triantafyllou, Panagiotis [1 ]
Juliebo-Jones, Patrick [5 ]
Somani, Bhaskar [6 ]
Mitsogiannis, Iraklis [1 ]
Tzelves, Lazaros [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Sismanoglio Hosp, Dept Urol 2, Athens 15126, Greece
[2] Gen Hosp Athens G Gennimatas, Dept Urol, Athens 11527, Greece
[3] Red Cross Gen Hosp Athens, Dept Urol, Athens 11526, Greece
[4] Hellenic Open Univ, Sch Sci & Technol, Patras 26335, Greece
[5] Haukeland Hosp, Dept Urol, N-5009 Bergen, Norway
[6] Univ Hosp, Dept Urol, Southampton SO16 6YD, England
来源
LIFE-BASEL | 2024年 / 14卷 / 07期
关键词
salvage radical prostatectomy; prostate cancer; salvage therapy; robotic prostatectomy; recurrence; ANDROGEN-DEPRIVATION THERAPY; INTENSITY FOCUSED ULTRASOUND; FUNCTIONAL OUTCOMES; MULTIPARAMETRIC MRI; FOCAL THERAPY; RADIATION; RADIOTHERAPY; MORBIDITY; ABLATION; DISEASE;
D O I
10.3390/life14070868
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prostate cancer is the second most common cancer among men, with many treatment modalities available for patients, such as radical prostatectomy, external beam radiotherapy, brachytherapy, high-intensity focused ultrasound, cryotherapy, electroporation and other whole-gland or focal ablative novel techniques. Unfortunately, up to 60% of men with prostate cancer experience recurrence at 5 to 10 years. Salvage radical prostatectomy can be offered as an option in the setting of recurrence after a primary non-surgical treatment. However, the complexity of salvage radical prostatectomy is considered to be greater than that of primary surgery, making it the least popular treatment of choice. With the wide use of robotic platforms in urologic oncologic surgery, salvage radical prostatectomy has attracted attention again because, compared to past data, modern series involving salvage Robot-Assisted Radical Prostatectomy have shown promising results. In this narrative literature review, we comprehensively examined data on salvage radical prostatectomy. We investigated the correlation between the different types of primary prostate cancer therapy and the following salvage radical prostatectomy. Furthermore, we explored the concept of a robotic approach and its beneficial effect in salvage surgery. Lastly, we emphasized several promising avenues for future research in this field.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Salvage radical prostatectomy after failure of radiotherapy for localized prostate cancer
    Rigaud, J
    Tiguert, R
    Fradet, Y
    Bouchot, O
    PROGRES EN UROLOGIE, 2002, 12 (06): : 1179 - 1187
  • [32] Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients
    Gandaglia, Giorgio
    Briganti, Alberto
    Clarke, Noel
    Karnes, R. Jeffrey
    Graefen, Markus
    Ost, Piet
    Zietman, Anthony Laurence
    Roach, Mack, III
    EUROPEAN UROLOGY, 2017, 72 (05) : 689 - 709
  • [33] Salvage Radical Prostatectomy in Nonmetastatic Castration-Resistant Prostate Cancer
    Lopez-Fontana, Gaston
    Manuel Guglielmi, Juan
    Lopez-Fontana, Rodrigo
    Lis Hinojosa-Jury, Mariana
    Lopez-Fontana, Constanza
    Daniel Lopez-Laur, Jose
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (07): : 638 - 641
  • [34] Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy
    Macdonald, K
    Schild, SE
    Vora, SA
    Andrews, PE
    Ferrigni, RG
    Novicki, DE
    Swanson, SK
    Wong, WW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05): : 1530 - 1535
  • [35] Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study
    Miyake, Makito
    Tanaka, Nobumichi
    Asakawa, Isao
    Morizawa, Yosuke
    Anai, Satoshi
    Torimoto, Kazumasa
    Aoki, Katsuya
    Yoneda, Tatsuo
    Hasegawa, Masatoshi
    Konishi, Noboru
    Fujimoto, Kiyohide
    RADIATION ONCOLOGY, 2014, 9
  • [36] Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic Review
    Schroeder, Christina
    Tang, Hongjian
    Windisch, Paul
    Zwahlen, Daniel Rudolf
    Buchali, Andre
    Vu, Erwin
    Bostel, Tilman
    Sprave, Tanja
    Zilli, Thomas
    Murthy, Vedang
    Foerster, Robert
    CANCERS, 2022, 14 (03)
  • [37] Functional Outcomes after Local Salvage Therapies for Radiation-Recurrent Prostate Cancer Patients: A Systematic Review
    Abufaraj, Mohammad
    Siyam, Abdelmuez
    Ali, Mustafa Rami
    Suarez-Ibarrola, Rodrigo
    Yang, Lin
    Foerster, Beat
    Shariat, Shahrokh F.
    CANCERS, 2021, 13 (02) : 1 - 16
  • [38] Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
    Ann-Kathrin Oehus
    Stephanie G. C. Kroeze
    Nina-Sophie Schmidt-Hegemann
    Marco M. E. Vogel
    Simon Kirste
    Jessica Becker
    Irene A. Burger
    Thorsten Derlin
    Peter Bartenstein
    Matthias Eiber
    Michael Mix
    Christian la Fougère
    Claus Belka
    Stephanie E. Combs
    Anca-Ligia Grosu
    Arndt-Christian Müller
    Matthias Guckenberger
    Hans Christiansen
    Christoph Henkenberens
    BMC Cancer, 20
  • [39] Salvage radical prostatectomy for radiorecurrent prostate cancer: Morbidity revisited
    Vaidya, A
    Soloway, MS
    JOURNAL OF UROLOGY, 2000, 164 (06) : 1998 - 2001
  • [40] Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER
    Wenzel, Mike
    Wuernschimmel, Christoph
    Nocera, Luigi
    Ruvolo, Claudia Colla
    Tian, Zhe
    Shariat, Shahrokh F.
    Saad, Fred
    Briganti, Alberto
    Graefen, Markus
    Becker, Andreas
    Kluth, Luis A.
    Mandel, Philipp
    Chun, Felix K. H.
    Karakiewicz, Pierre, I
    CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : E255 - E263